THE Therapeutic Goods
Administration has approved a new
orphan drug designation for
Novartis Pharmaceuticals Afinitor
(everolimus) 5mg and 10mg
tablets, indicated for use in the
treatment of advanced renal cell
carcinoma.
For more info- www.tga.gov.au.The above article was sent to subscribers in Pharmacy Daily's issue from 02 Aug 10 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Aug 10
THE role and significance of community pharmacy in regional areas was a key focus of discussion for the Nationals leader David Littleproud during last week’s visit to Orana Mall Pharmacy as part of a regional tour.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.